{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:48:02Z","timestamp":1794635282755,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014454","name":"Leonard M. Miller School of Medicine, University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014454","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.10.041","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T15:49:05Z","timestamp":1604418545000},"page":"7989-7997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vaccination against cocaine using a modifiable dendrimer nanoparticle platform"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1792-5531","authenticated-orcid":false,"given":"Jeffrey A.","family":"Lowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Dikici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha M.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-7576","authenticated-orcid":false,"given":"Vance P.","family":"Lemmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Daunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Izenwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirouz","family":"Daftarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.10.041_b0005","unstructured":"National Institute on Drug Abuse. National survey of drug use and health; 2016."},{"key":"10.1016\/j.vaccine.2020.10.041_b0010","unstructured":"United Nations Office on Drugs and Crime. World drug report 2019; 2019."},{"key":"10.1016\/j.vaccine.2020.10.041_b0015","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.vaccine.2020.10.041_b0020","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2020.10.041_b0025","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/026988119901300406","article-title":"Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans","volume":"13","author":"Volkow","year":"1999","journal-title":"J Psychopharmac (Oxford, England)"},{"key":"10.1016\/j.vaccine.2020.10.041_b0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/WNR.0b013e32831b9ce4","article-title":"Cocaine does not produce reward in absence of dopamine transporter inhibition","volume":"20","author":"Tilley","year":"2009","journal-title":"NeuroReport"},{"key":"10.1016\/j.vaccine.2020.10.041_b0035","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.neuroscience.2009.06.068","article-title":"Social and physical environment alter cocaine conditioned place preference and dopaminergic markers in adolescent male rats","volume":"163","author":"Zakharova","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.vaccine.2020.10.041_b0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1124\/jpet.109.159897","article-title":"Low or high cocaine responding rats differ in striatal extracellular dopamine levels and dopamine transporter number","volume":"331","author":"Nelson","year":"2009","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"10.1016\/j.vaccine.2020.10.041_b0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pharmthera.2013.04.011","article-title":"Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy","volume":"139","author":"Loftis","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2020.10.041_b0050","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2174\/138161211796150873","article-title":"Pharmacological treatments for cocaine dependence: is there something new?","volume":"17","author":"Karila","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.vaccine.2020.10.041_b0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pr.117.013904","article-title":"Conjugate vaccine immunotherapy for substance use disorder","volume":"69","author":"Bremer","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.vaccine.2020.10.041_b0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/14760584.2017.1378577","article-title":"Current status and future prospects for the development of substance abuse vaccines","volume":"16","author":"Heekin","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.10.041_b0065","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.drudis.2019.07.009","article-title":"Immunotherapy for treating methamphetamine, heroin and cocaine use disorders","volume":"25","author":"Xiaoshan","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2020.10.041_b0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/npp.2011.200","article-title":"Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects","volume":"37","author":"Wee","year":"2012","journal-title":"Neuropsychopharmac: Off Publ Am College Neuropsychopharmac"},{"key":"10.1016\/j.vaccine.2020.10.041_b0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.vaccine.2020.10.041_b0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s002130000555","article-title":"Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010","volume":"153","author":"Kantak","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.vaccine.2020.10.041_b0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines against drug abuse","volume":"91","author":"Shen","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2020.10.041_b0090","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/mt.2010.280","article-title":"Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs","volume":"19","author":"Hicks","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2020.10.041_b0095","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2020.10.041_b0100","first-page":"7301","article-title":"The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse","volume":"52","author":"Carroll","year":"2009","journal-title":"J MedChem"},{"key":"10.1016\/j.vaccine.2020.10.041_b0105","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/infdis\/jit378","article-title":"A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis","volume":"208","author":"Daftarian","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.10.041_b0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.intimp.2016.03.028","article-title":"Optimization of a methamphetamine conjugate vaccine for antibody production in mice","volume":"35","author":"Stevens","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2020.10.041_b0115","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1158\/0008-5472.CAN-11-1766","article-title":"Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells","volume":"71","author":"Daftarian","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2020.10.041_b0120","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1021\/jo010965g","article-title":"Oxidation of primary amines to oxaziridines using molecular oxygen (O2) as the ultimate oxidant","volume":"66","author":"Lin","year":"2001","journal-title":"J Org Chem"},{"key":"10.1016\/j.vaccine.2020.10.041_b0125","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/anie.200462207","article-title":"A mild and selective method for the hydrolysis of esters with trimethyltin hydroxide","volume":"44","author":"Nicolaou","year":"2005","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.vaccine.2020.10.041_b0130","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm1096-1129","article-title":"Efficacy of a therapeutic cocaine vaccine in rodent models","volume":"2","author":"Fox","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.10.041_b0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2020.10.041_b0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbr.2008.10.019","article-title":"Differential effects of methamphetamine and cocaine on conditioned place preference and locomotor activity in adult and adolescent male rats","volume":"198","author":"Zakharova","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.vaccine.2020.10.041_b0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pbb.2008.11.002","article-title":"Sensitivity to cocaine conditioned reward depends on sex and age","volume":"92","author":"Zakharova","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.vaccine.2020.10.041_b0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","article-title":"Conditioned place preference: what does it add to our preclinical understanding of drug reward?","volume":"153","author":"Bardo","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.vaccine.2020.10.041_b0155","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1016\/0040-4039(96)01170-7","article-title":"Design and synthesis of a cocaine-diamide hapten for vaccine development","volume":"37","author":"Sakurai","year":"1996","journal-title":"TetrahedronLett"},{"key":"10.1016\/j.vaccine.2020.10.041_b0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/acsmedchemlett.8b00051","article-title":"Efficient syntheses of cocaine vaccines and their in vivo evaluation","volume":"9","author":"Kimishima","year":"2018","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.vaccine.2020.10.041_b0165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2174\/187152711799219334","article-title":"Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus","volume":"10","author":"Koob","year":"2011","journal-title":"CNS Neurol Disord: Drug Targets"},{"issue":"30","key":"10.1016\/j.vaccine.2020.10.041_b0170","first-page":"409","article-title":"In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations","volume":"2011","author":"Daftarian","year":"2005","journal-title":"Hybridoma"},{"key":"10.1016\/j.vaccine.2020.10.041_b0175","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.vaccine.2020.10.041_b0180","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1073\/pnas.93.22.12467","article-title":"Genetic mapping of a murine locus controlling development of T helper 1\/T helper 2 type responses","volume":"93","author":"Gorham","year":"1996","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2020.10.041_b0185","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1128\/IAI.70.12.6638-6645.2002","article-title":"Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB\/c and C57BL\/6 mice","volume":"70","author":"Liu","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.10.041_b0190","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.271.5251.984","article-title":"Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development","volume":"271","author":"G\u00fcler","year":"1996","journal-title":"Science (New York, NY)."},{"key":"10.1016\/j.vaccine.2020.10.041_b0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.10.041_b0200","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.181.2.713","article-title":"T cell genetic background determines default T helper phenotype development in vitro","volume":"181","author":"Hsieh","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.10.041_b0205","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2020.10.041_b0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.10.041_b0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00024382-200210000-00009","article-title":"Genetic contribution to the septic response in a mouse model","volume":"18","author":"Stewart","year":"2002","journal-title":"Shock (Augusta, Ga)."},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2020.10.041_b0220","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","article-title":"Unmet needs in modern vaccinology: adjuvants to improve the immune response","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.041_b0225","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1016\/j.vaccine.2007.06.049","article-title":"Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response","volume":"25","author":"Hansen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.041_b0230","doi-asserted-by":"crossref","first-page":"102023","DOI":"10.1016\/j.nano.2019.102023","article-title":"Alum as an adjuvant for nanoparticle based vaccines: a case study with a hybrid nanoparticle-based nicotine vaccine","volume":"20","author":"Hu","year":"2019","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.vaccine.2020.10.041_b0235","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.vaccine.2010.02.085","article-title":"Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response","volume":"28","author":"Noe","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.10.041_b0240","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1021\/mp400214w","article-title":"Probing the effects of hapten stability on cocaine vaccine immunogenicity","volume":"10","author":"Cai","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2020.10.041_b0245","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1021\/acs.molpharmaceut.6b00682","article-title":"Cocaine vaccine development: evaluation of carrier and adjuvant combinations that activate multiple toll-like receptors","volume":"13","author":"Kimishima","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2020.10.041_b0250","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.bmcl.2017.12.043","article-title":"Investigations into the efficacy of multi-component cocaine vaccines","volume":"28","author":"Kimishima","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.vaccine.2020.10.041_b0255","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.10.041_b0260","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/humc.2013.231","article-title":"Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine","volume":"25","author":"Hicks","year":"2014","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.vaccine.2020.10.041_b0265","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pbb.2016.09.008","article-title":"Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques","volume":"150\u2013151","author":"Evans","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.vaccine.2020.10.041_b0270","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.98.4.1988","article-title":"A second-generation vaccine protects against the psychoactive effects of cocaine","volume":"98","author":"Carrera","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2020.10.041_b0275","first-page":"3701","article-title":"Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design","volume":"56","author":"Cai","year":"2013","journal-title":"J MedChem"},{"key":"10.1016\/j.vaccine.2020.10.041_b0280","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1038\/npp.2013.114","article-title":"Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter","volume":"38","author":"Maoz","year":"2013","journal-title":"Neuropsychopharmacol: Off Publ Am College Neuropsychopharmac"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20313359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:57Z","timestamp":1759402197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20313359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":56,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X20313359"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.041","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739006950.793580228","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination against cocaine using a modifiable dendrimer nanoparticle platform","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}